| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adapted vaccine strategy: facing the persistent challenges of COVID-19
|
Shang, Lianhan
|
|
|
23 |
9 |
p. 984-985
|
artikel
|
| 2 |
All-cause and pathogen-specific lower respiratory tract infection hospital admissions in children younger than 5 years during the COVID-19 pandemic (2020–22) compared with the pre-pandemic period (2015–19) in South Africa: an observational study
|
Izu, Alane
|
|
|
23 |
9 |
p. 1031-1041
|
artikel
|
| 3 |
A milestone in malaria prevention
|
Balakrishnan, Vijay Shankar
|
|
|
23 |
9 |
p. e340-e341
|
artikel
|
| 4 |
Control of tuberculosis in Cuba: history of a success
|
Bagcchi, Sanjeet
|
|
|
23 |
9 |
p. 1005
|
artikel
|
| 5 |
Correction to Lancet Infect Dis 2022; 22: 97–109
|
|
|
|
23 |
9 |
p. e337
|
artikel
|
| 6 |
Correction to Lancet Infect Dis 2023; 23: 789
|
|
|
|
23 |
9 |
p. e337
|
artikel
|
| 7 |
Correction to Lancet Infect Dis 2023; published online May 23. https://doi.org/10.1016/S1473-3099(23)00213-X
|
|
|
|
23 |
9 |
p. e337
|
artikel
|
| 8 |
CS-2034 mRNA vaccine: a new option for COVID-19 infection?
|
Zhang, Ruiqi
|
|
|
23 |
9 |
p. 986-987
|
artikel
|
| 9 |
Dengue outbreak in Peru affects adults and children
|
Sanjeet Bagcchi,
|
|
|
23 |
9 |
p. e339
|
artikel
|
| 10 |
Detection of five instances of dual-clade infections of Candida auris with opposite mating types in southern Nevada, USA
|
Massic, Lauryn
|
|
|
23 |
9 |
p. e328-e329
|
artikel
|
| 11 |
Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara–Bavaria Nordic vaccine against mpox in children: a national outbreak response
|
Ladhani, Shamez N
|
|
|
23 |
9 |
p. 1042-1050
|
artikel
|
| 12 |
Effectiveness of national and subnational interventions for prevention and control of health-care-associated infections in acute hospitals in high-income and upper-middle-income counties: a systematic review update
|
Price, Lesley
|
|
|
23 |
9 |
p. e347-e360
|
artikel
|
| 13 |
Efficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)
|
Kaye, Keith S
|
|
|
23 |
9 |
p. 1072-1084
|
artikel
|
| 14 |
Elizabeth Bukusi—ethics expert, researcher, and educator
|
Kirby, Tony
|
|
|
23 |
9 |
p. 1002
|
artikel
|
| 15 |
Extragenital gonorrhoea, chlamydia, and HIV co-infection in people with mpox
|
Herrera, Kara
|
|
|
23 |
9 |
p. e334-e336
|
artikel
|
| 16 |
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial
|
Ogutu, Bernhards
|
|
|
23 |
9 |
p. 1051-1061
|
artikel
|
| 17 |
Ganaplacide plus lumefantrine solid dispersion formulation: considerations for development and rollout
|
Chen, Ingrid
|
|
|
23 |
9 |
p. 990-992
|
artikel
|
| 18 |
Global progress reported for AIDS
|
Jesudason, Timothy
|
|
|
23 |
9 |
p. e342
|
artikel
|
| 19 |
Hantavirus in humans: a review of clinical aspects and management
|
Vial, Pablo A
|
|
|
23 |
9 |
p. e371-e382
|
artikel
|
| 20 |
Harald zur Hausen
|
Bagcchi, Sanjeet
|
|
|
23 |
9 |
p. 1001
|
artikel
|
| 21 |
Hospital admissions for group A streptococcal infections in England: current rates and historical perspective
|
Iro, Mildred A
|
|
|
23 |
9 |
p. e326-e327
|
artikel
|
| 22 |
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial
|
Wilkinson, Amanda L
|
|
|
23 |
9 |
p. 1062-1071
|
artikel
|
| 23 |
Implementation of point-of-care testing of C-reactive protein concentrations to improve antibiotic targeting in respiratory illness in Vietnamese primary care: a pragmatic cluster-randomised controlled trial
|
Do, Nga Thi Thuy
|
|
|
23 |
9 |
p. 1085-1094
|
artikel
|
| 24 |
Infectious diseases in the COVID-19 era: gaps between countries
|
Levy, Corinne
|
|
|
23 |
9 |
p. 987-988
|
artikel
|
| 25 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
23 |
9 |
p. e345
|
artikel
|
| 26 |
Lessons from COVID-19 for rescalable data collection
|
Bhatia, Sangeeta
|
|
|
23 |
9 |
p. e383-e388
|
artikel
|
| 27 |
Microbiome-based therapeutics for Clostridioides difficile infection: helpful solutions or unclear cocktails?
|
Hota, Susy S
|
|
|
23 |
9 |
p. 999-1000
|
artikel
|
| 28 |
Modified vaccinia Ankara–Bavarian Nordic vaccine against mpox in children
|
Turtle, Lance
|
|
|
23 |
9 |
p. 989-990
|
artikel
|
| 29 |
Multiple fungating masses on the abdomen due to Actinomyces
|
Ramirez, Denisse
|
|
|
23 |
9 |
p. e389
|
artikel
|
| 30 |
Negligible role of suppressed HIV in sexual transmission
|
The Lancet Infectious Diseases,
|
|
|
23 |
9 |
p. 983
|
artikel
|
| 31 |
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial
|
Lee, Ivan T
|
|
|
23 |
9 |
p. 1007-1019
|
artikel
|
| 32 |
Polio endgame complexity: updating expectations for nOPV2
|
Thompson, Kimberly M
|
|
|
23 |
9 |
p. 992-994
|
artikel
|
| 33 |
Pre-emptively tackling vaccine misinformation for a successful large-scale roll-out of malaria vaccines in Africa
|
Titanji, Boghuma K
|
|
|
23 |
9 |
p. 997-999
|
artikel
|
| 34 |
Preparing for Disease X
|
Ramgolam, Aimee
|
|
|
23 |
9 |
p. 1004
|
artikel
|
| 35 |
Questioning bedaquiline availability
|
Holt, Edward
|
|
|
23 |
9 |
p. e338
|
artikel
|
| 36 |
Research in brief
|
Devi, Sharmila
|
|
|
23 |
9 |
p. e346
|
artikel
|
| 37 |
Risk of highly pathogenic avian influenza to humans
|
Burki, Talha
|
|
|
23 |
9 |
p. e343-e344
|
artikel
|
| 38 |
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial
|
Wu, Jun-Dong
|
|
|
23 |
9 |
p. 1020-1030
|
artikel
|
| 39 |
The Enhanced Gonococcal Surveillance Programme, Cambodia
|
Ouk, Vichea
|
|
|
23 |
9 |
p. e332-e333
|
artikel
|
| 40 |
The father of hospital hygiene
|
De Ambrogi, Marco
|
|
|
23 |
9 |
p. 1003
|
artikel
|
| 41 |
The incalculable debts of South Africa's gold mines
|
Ramgolam, Aimee
|
|
|
23 |
9 |
p. 1006
|
artikel
|
| 42 |
The largest reported outbreak of CCHF in hospital settings: lessons from Kandahar, Afghanistan
|
Gaina, Alexandru
|
|
|
23 |
9 |
p. e330-e331
|
artikel
|
| 43 |
Treating carbapenem-resistant Acinetobacter baumannii infections
|
Giannella, Maddalena
|
|
|
23 |
9 |
p. 994-995
|
artikel
|
| 44 |
Use of point-of-care biomarkers to reduce antibiotic resistance
|
Hui, David S C
|
|
|
23 |
9 |
p. 996-997
|
artikel
|
| 45 |
Worldwide dispensing of non-prescription antibiotics in community pharmacies and associated factors: a mixed-methods systematic review
|
Li, Jinxi
|
|
|
23 |
9 |
p. e361-e370
|
artikel
|
Tijdschrift beschrijving